SAFETY OF TO FACITINIB COMPARED TO BIOLOGICAL DMARDS IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE: OVERVIEW OF SYSTEMATIC REVIEWS

被引：0
|
作者：
Reyes, J. M. [1 ]
Rodriguez, A. [2 ]
机构：
[1] Pfizer SAS, Bogota, Colombia
[2] Univ Nacl Colombia, Bogota, Colombia
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.887
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS2
引用
收藏
页码：A152 / A153
页数：4
相关论文
共 50 条
  • [31] SAFETY AND EFFICACY OF OCRELIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE OR TUMOUR NECROSIS FACTOR INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ahmed, Hussien
    Abushouk, Abdelrahman Ibrahim
    Ismail, Ammar
    Elmaraezy, Ahmed
    Badr, Ahmed Said
    Gadelkarim, Mohamed
    Elnenny, Mohammed
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A8 - A8
  • [32] Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and meta-analysis
    Abdelrahman Ibrahim Abushouk
    Hussien Ahmed
    Ammar Ismail
    Ahmed Elmaraezy
    Ahmed Said Badr
    Mohamed Gadelkarim
    Mohammed Elnenny
    Rheumatology International, 2017, 37 : 1053 - 1064
  • [33] Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate
    Lee, Won-Seok
    Lee, Sang-Il
    Lee, Myeung-Soo
    Kim, Sung-Il
    Lee, Shin-Seok
    Yoo, Wan-Hee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (04): : 779 - 787
  • [34] A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
    Pavelka, Karel
    Chon, Yun
    Newmark, Richard
    Lin, Shao-Lee
    Baumgartner, Scott
    Erondu, Ngozi
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (06) : 912 - 919
  • [35] PSYCHOLOGICAL INTERVENTIONS FOR RHEUMATOID ARTHRITIS: AN OVERVIEW OF SYSTEMATIC REVIEWS
    Prothero, Louise
    Barley, Elizabeth
    Galloway, James
    Georgopoulou, Sofia
    Sturt, Jackie
    RHEUMATOLOGY, 2016, 55 : 121 - 122
  • [36] Upadacitinib in Patients with Rheumatoid Arthritis and Inadequate Response or Intolerance to Biological DMARDs: Results at 60 weeks from the SELECT-BEYOND Study
    Andrea, Rubbert-Roth
    Genovese, M. C.
    Combe, B.
    Hall, S.
    Sheng, Zhong
    Sebastian, Meerwein
    Roy, Fleischmann
    SWISS MEDICAL WEEKLY, 2019, : 7S - 7S
  • [37] Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab
    Ornetti, P
    Solau, E
    Gaudin, P
    Sibilia, J
    Berthelot, JM
    Puechal, X
    Tavernier, C
    Maillefert, JF
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) : 1379 - 1380
  • [38] Cost-effectiveness of treatment strategies for rheumatoid arthritis patients with inadequate response to methotrexate
    Patel, VD
    Hay, J
    VALUE IN HEALTH, 2004, 7 (03) : 241 - 241
  • [39] Efficacy of Adding Iguratimod Therapy in Rheumatoid Arthritis Patients Who Had Inadequate Response to Biologic Dmards
    Miyamoto, Toshiaki
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [40] UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS: RESULTS AT 60 WEEKS FROM THE SELECT-BEYOND STUDY
    Genovese, Mark C.
    Combe, Bernard
    Hall, Stephen
    Rubbert-Roth, Andrea
    Zhong, Sheng
    Meerwein, Sebastian
    Pangan, Aileen
    Fleischmann, Roy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 360 - 361
12345